Parse Owes $4.9M In Cell Analysis Patent Case, Jury Finds
A Delaware federal jury put Parse Biosciences Inc. on the hook for $4.9 million after finding Friday that the biotechnology company infringed a trio of Roche Sequencing Solutions Inc. patents covering...To view the full article, register now.
Already a subscriber? Click here to view full article